Corbus Pharmaceuticals Holdings, Inc.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Corbus Pharmaceuticals Holdings is a clinical-stage biopharmaceutical company developing small-molecule drug candidates for cancer and other diseases, including therapies targeting fibrotic and inflammatory conditions.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Cormorant Asset Management, LPInsider | Sell | $1.74M | 425,000at $4.10 | Oct 29, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable CRBP activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.